Demant A/S (CO:DEMANT) — Market Cap & Net Worth
Market Cap & Net Worth: Demant A/S (DEMANT)
Demant A/S (CO:DEMANT) has a market capitalization of $11.85 Billion (Dkr75.71 Billion) as of October 16, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #1935 globally and #13 in its home market, demonstrating a 11.70% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Demant A/S's stock price Dkr359.00 by its total outstanding shares 210898609 (210.90 Million).
Demant A/S Market Cap History: 2015 to 2026
Demant A/S's market capitalization history from 2015 to 2026. Data shows growth from $4.34 Billion to $11.85 Billion (10.31% CAGR). Check Demant A/S share price for real-time trading data and today's change.
Demant A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Demant A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see DEMANT cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.31x
Demant A/S's market cap is 0.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.60x
Demant A/S's market cap is 4.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $4.05 Billion | $12.00 Billion | $1.46 Billion | 0.34x | 2.78x |
| 2017 | $5.72 Billion | $13.19 Billion | $1.75 Billion | 0.43x | 3.26x |
| 2018 | $6.10 Billion | $13.94 Billion | $1.82 Billion | 0.44x | 3.35x |
| 2019 | $6.92 Billion | $14.95 Billion | $1.46 Billion | 0.46x | 4.74x |
| 2020 | $7.94 Billion | $14.47 Billion | $1.12 Billion | 0.55x | 7.08x |
| 2021 | $11.06 Billion | $18.39 Billion | $2.51 Billion | 0.60x | 4.40x |
| 2022 | $6.35 Billion | $19.70 Billion | $2.08 Billion | 0.32x | 3.05x |
| 2023 | $9.77 Billion | $22.44 Billion | $1.79 Billion | 0.44x | 5.44x |
| 2024 | $8.72 Billion | $22.42 Billion | $2.39 Billion | 0.39x | 3.65x |
| 2025 | $7.10 Billion | $23.08 Billion | $1.54 Billion | 0.31x | 4.60x |
Competitor Companies of DEMANT by Market Capitalization
Companies near Demant A/S in the global market cap rankings as of October 16, 2026. See DEMANT equity to assets ratio to understand what proportion of total assets are financed by equity.
Key companies related to Demant A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #118 globally with a market cap of $182.03 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #223 globally with a market cap of $112.48 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #118 | Abbott Laboratories | NYSE:ABT | $182.03 Billion | $104.68 |
| #223 | Stryker Corporation | NYSE:SYK | $112.48 Billion | $293.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $95.45 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Demant A/S Historical Marketcap From 2015 to 2026
Between 2015 and today, Demant A/S's market cap moved from $4.34 Billion to $ 11.85 Billion, with a yearly change of 10.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr11.85 Billion | +66.82% |
| 2025 | Dkr7.10 Billion | -18.55% |
| 2024 | Dkr8.72 Billion | -10.74% |
| 2023 | Dkr9.77 Billion | +53.73% |
| 2022 | Dkr6.35 Billion | -42.54% |
| 2021 | Dkr11.06 Billion | +39.28% |
| 2020 | Dkr7.94 Billion | +14.68% |
| 2019 | Dkr6.92 Billion | +13.47% |
| 2018 | Dkr6.10 Billion | +6.57% |
| 2017 | Dkr5.72 Billion | +41.29% |
| 2016 | Dkr4.05 Billion | -6.54% |
| 2015 | Dkr4.34 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 16th, 2026 the market cap of Demant A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.85 Billion USD |
| MoneyControl | $11.85 Billion USD |
| MarketWatch | $11.85 Billion USD |
| marketcap.company | $11.85 Billion USD |
| Reuters | $11.85 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hol… Read more